ZURICH (Reuters) - Novartis said on Monday European regulators approved Afinitor to treat women with a certain type of breast cancer, following a panel backing in June. The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. ...Read the full article...
(From Yahoo Diseases)
Source: http://neurotalk.psychcentral.com/showthread.php?t=173990
sturgis sturgis whitney houston laid to rest daytona bike week amazing race maya angelou mary kay ash
No comments:
Post a Comment